In detail, 78% of the cases overexpressed Sirt7, 19% did not change the expression of Sirt7 and 3% under-expressed Sirt7 in gastric cancer tissues compared with the AGM (Fig. 1D). This evidence concerns the gene SIRT7 and gastric cancer.